Skip to main content
. 2009 Jun 2;101(1):160–165. doi: 10.1038/sj.bjc.6605106

Table 3a. Association of oestrogen receptor α (ER-α) serum bioactivity with risk of breast cancer.

    Cases
ER-α serum bioactivity (pg ml−1)
Controls All
ER-negative
ER-positive
Quintilea Range N (%) N (%) OR (95% CI)b N (%) OR (95% CI)b N (%) OR (95% CI)b
1st 0–13.8 24 (19.1) 24 (14.3) 1.00 (ref.) 4 (9.5) 1.00 (ref.) 20 (15.9) 1.00 (ref.)
2nd 13.9–21.6 26 (20.8) 25 (14.9) 1.00 (0.45–2.23) 7 (16.7) 1.53 (0.39–6.06) 18 (14.3) 0.92 (0.39–2.18)
3rd 21.7–29.5 25 (20.0) 23 (13.7) 0.97 (0.43–2.17) 12 (28.6) 3.22 (0.88–11.77) 11 (8.7) 0.53 (0.21–1.36)
4th 29.6–42.0 25 (20.0) 33 (19.6) 1.24 (0.57–2.71) 10 (23.8) 2.18 (0.59–8.11) 23 (18.3) 1.09 (0.47–2.52)
5th ⩾42.1 25 (20.0) 63 (37.5) 2.47 (1.17–5.20) 9 (21.4) 1.84 (0.49–6.89) 54 (42.9) 2.70 (1.23–5.90)
P-valuec       P=0.008   P=0.36   P=0.004
a

Quintiles according to distribution among controls.

b

Adjusted for age.

c

P-value for trend, adjusted for age.